PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-5.18%
Negative revenue growth while MRVL stands at 4.29%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-54.96%
Negative gross profit growth while MRVL is at 3.82%. Joel Greenblatt would examine cost competitiveness or demand decline.
23.89%
EBIT growth above 1.5x MRVL's 8.09%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
23.89%
Operating income growth 1.25-1.5x MRVL's 15.99%. Bruce Berkowitz would see if strategic measures (e.g., cost cutting, product mix) are succeeding.
5.19%
Positive net income growth while MRVL is negative. John Neff might see a big relative performance advantage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
1.97%
Slight or no buybacks while MRVL is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
1.97%
Diluted share count expanding well above MRVL's 1.17%. Michael Burry would fear significant dilution to existing owners' stakes.
-10.10%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
-70.45%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-120.49%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
36.26%
10Y revenue/share CAGR at 50-75% of MRVL's 56.20%. Martin Whitman would question if the firm’s offerings lag behind the competitor.
10.62%
5Y revenue/share CAGR under 50% of MRVL's 109.65%. Michael Burry would suspect a significant competitive gap or product weakness.
9.60%
3Y revenue/share CAGR under 50% of MRVL's 25.49%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
22.27%
3Y OCF/share CAGR under 50% of MRVL's 63.72%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
616.08%
Similar net income/share CAGR to MRVL's 653.69%. Walter Schloss would see parallel tailwinds or expansions for both firms.
-18.38%
Negative 5Y net income/share CAGR while MRVL is 220.76%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
456.75%
3Y net income/share CAGR above 1.5x MRVL's 202.86%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-27.07%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
No Data
No Data available this quarter, please select a different quarter.
33.94%
Stable or rising mid-term dividends while MRVL is cutting. John Neff sees an edge in consistent payouts vs. the competitor.
-18.09%
Both firms reduced dividends recently. Martin Whitman suspects broader macro or industry issues forcing cost and payout cuts.
3.28%
AR growth is negative/stable vs. MRVL's 11.24%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
4.50%
Inventory growth well above MRVL's 4.05%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
7.75%
Positive asset growth while MRVL is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
1.80%
Positive BV/share change while MRVL is negative. John Neff sees a clear edge over a competitor losing equity.
-2.91%
We’re deleveraging while MRVL stands at 3.89%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
0.30%
We expand SG&A while MRVL cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.